Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 5,000 shares at $80.69 ($410K) on 2017-04-03, disclosed to the SEC on 2017-04-04.
Open-market sale of $410k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.69 | 1,800 | $145K | 35.4% |
| 2 | $82.38 | 2,400 | $198K | 48.2% |
| 3 | $83.46 | 700 | $58K | 14.3% |
| 4 | $84.22 | 100 | $8K | 2.1% |
| Total | $81.96 avg | 5,000 | $410K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |